跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PCT-2
首页
药物
PCT-2
PCT-2
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
VIRAL DETECTION SYSTEMS AND USES THEREOF
EP 4182456 A1
申请人: UNIV BOSTON
优先权: 2020
EP
US
WO
3 件公开
Pharmaceutical combinations of 1-cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-urea
US 8435970 B2
申请人: CURRY JAYNE ELIZABETH
优先权: 2007
US
2 件公开
IMMUNOASSAY FOR THE DETECTION OF PROCALCITONIN
US 2012122114 A1
申请人: STRUCK JOACHIM
优先权: 2009
US
2 件公开
Processes for the preparation of O-[5-(4-amino-thiazol-2-yl)-pyridin-2-ylmethyl]-hydroxylamine
US 7842813 B2
申请人: ENANTA PHARM INC
优先权: 2009
US
2 件公开
Polycyclic phthalazine compounds and their use
US 6124290 A
申请人: GRUENENTHAL GMBH
优先权: 1996
US
Leukotriene B4 derivatives, in particular oximo-LTB4- antagonists
US 6160012 A
申请人: SCHERING AG
优先权: 1997
US
Use of a specific antagonist of 5HT2 receptors for preparaing medicines useful for treating sleep-disordered breathing
US 6143792 A
申请人: SANOFI SYNTHELABO
优先权: 1997
US
2-fluorofucosyl-N-aroylglucosamine derivatives, intermediates, therefor, and processes for producing these
US 6143724 A
申请人: DAIKIN IND LTD
优先权: 1997
US
Substituted 3-phenylisoxazolines
US 6150303 A
申请人: BASF AG
优先权: 1997
US
Histamine H3 receptor ligands
US 6159994 A
申请人: JAMES BLACK FOUNDATION
优先权: 1997
US
第 1 / 3 页
上一页
下一页
药物
反馈